Ohh M - Search Results

1

Suppression of hypoxia-inducible factor 2alpha restores p53 activity via Hdm2 and reverses chemoresistance of renal carcinoma cells.

Roberts AM, Watson IR, Evans AJ, Foster DA, Irwin MS, Ohh M. Roberts AM, et al. Among authors: ohh m. Cancer Res. 2009 Dec 1;69(23):9056-64. doi: 10.1158/0008-5472.CAN-09-1770. Epub 2009 Nov 17. Cancer Res. 2009. PMID: 19920202 Free PMC article.

2

The von Hippel-Lindau tumor suppressor protein sensitizes renal cell carcinoma cells to tumor necrosis factor-induced cytotoxicity by suppressing the nuclear factor-kappaB-dependent antiapoptotic pathway.

Qi H, Ohh M. Qi H, et al. Among authors: ohh m. Cancer Res. 2003 Nov 1;63(21):7076-80. Cancer Res. 2003. PMID: 14612498

3

Von Hippel-Lindau tumor suppressor protein and hypoxia-inducible factor in kidney cancer.

Maynard MA, Ohh M. Maynard MA, et al. Among authors: ohh m. Am J Nephrol. 2004 Jan-Feb;24(1):1-13. doi: 10.1159/000075346. Epub 2003 Dec 3. Am J Nephrol. 2004. PMID: 14654728 Review.

4

Molecular cloning and characterization of the von Hippel-Lindau-like protein.

Qi H, Gervais ML, Li W, DeCaprio JA, Challis JR, Ohh M. Qi H, et al. Among authors: ohh m. Mol Cancer Res. 2004 Jan;2(1):43-52. Mol Cancer Res. 2004. PMID: 14757845

5

The role of von Hippel-Lindau tumor suppressor protein and hypoxia in renal clear cell carcinoma.

Sufan RI, Jewett MA, Ohh M. Sufan RI, et al. Among authors: ohh m. Am J Physiol Renal Physiol. 2004 Jul;287(1):F1-6. doi: 10.1152/ajprenal.00424.2003. Am J Physiol Renal Physiol. 2004. PMID: 15180922 Free article. Review.

6

Expression of p53 in renal carcinoma cells is independent of pVHL.

Stickle NH, Cheng LS, Watson IR, Alon N, Malkin D, Irwin MS, Ohh M. Stickle NH, et al. Among authors: ohh m. Mutat Res. 2005 Oct 15;578(1-2):23-32. doi: 10.1016/j.mrfmmm.2005.02.016. Epub 2005 Jul 5. Mutat Res. 2005. PMID: 15998523

7

Molecular targets from VHL studies into the oxygen-sensing pathway.

Maynard MA, Ohh M. Maynard MA, et al. Among authors: ohh m. Curr Cancer Drug Targets. 2005 Aug;5(5):345-56. doi: 10.2174/1568009054629672. Curr Cancer Drug Targets. 2005. PMID: 16101382 Review.

8

Human HIF-3alpha4 is a dominant-negative regulator of HIF-1 and is down-regulated in renal cell carcinoma.

Maynard MA, Evans AJ, Hosomi T, Hara S, Jewett MA, Ohh M. Maynard MA, et al. Among authors: ohh m. FASEB J. 2005 Sep;19(11):1396-406. doi: 10.1096/fj.05-3788com. FASEB J. 2005. PMID: 16126907

9

Homotypic association between tumour-associated VHL proteins leads to the restoration of HIF pathway.

Chung J, Roberts AM, Chow J, Coady-Osberg N, Ohh M. Chung J, et al. Among authors: ohh m. Oncogene. 2006 May 18;25(21):3079-83. doi: 10.1038/sj.onc.1209328. Oncogene. 2006. PMID: 16407835

10

Characterization of a von Hippel Lindau pathway involved in extracellular matrix remodeling, cell invasion, and angiogenesis.

Kurban G, Hudon V, Duplan E, Ohh M, Pause A. Kurban G, et al. Among authors: ohh m. Cancer Res. 2006 Feb 1;66(3):1313-9. doi: 10.1158/0008-5472.CAN-05-2560. Cancer Res. 2006. PMID: 16452184

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

102 results

Search Page

Filters